JOCK ITCH SPRAY

JOCK ITCH SPRAY was reported 1356 times

JOCK ITCH SPRAY is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPOXANTHINE-GUANINE PHOSPHORIBOSYL TRANSFERASE DEFICIENCY 1 0.3333
1 ELEPHANTIASIS NOSTRAS VERRUCOSA 1 0.1250
2 ANTI-HLA ANTIBODY TEST POSITIVE 1 0.0588
3 HEPATITIS SYPHILITIC 1 0.0556
4 HUMAN T-CELL LYMPHOTROPIC VIRUS INFECTION 1 0.0417
5 VULVOVAGINAL BURNING SENSATION 242 0.0396
6 CHEMICAL BURN OF GENITALIA 4 0.0328
7 CONJUNCTIVOCHALASIS 1 0.0323
8 INSTILLATION SITE HAEMORRHAGE 1 0.0256
9 BEREAVEMENT 1 0.0217
10 MIXED HYPERLIPIDAEMIA 1 0.0192
11 FUNGAL RHINITIS 2 0.0187
12 VULVOVAGINAL PAIN 79 0.0164
13 VULVOVAGINAL PRURITUS 73 0.0144
14 DISRUPTIVE MOOD DYSREGULATION DISORDER 1 0.0135
15 KAWASAKI'S DISEASE 1 0.0132
16 AORTIC VALVE DISEASE MIXED 1 0.0123
17 PERIPHERAL NERVE LESION 4 0.0121
18 ACUTE MONOCYTIC LEUKAEMIA 2 0.0110
19 VULVOVAGINAL DISCOMFORT 47 0.0106
20 LOBULAR BREAST CARCINOMA IN SITU 1 0.0105
21 ALLERGY TO IMMUNOGLOBULIN THERAPY 1 0.0092
22 ELECTROCONVULSIVE THERAPY 1 0.0092
23 CATHETER THROMBOSIS 1 0.0089
24 VAGINAL MUCOSAL BLISTERING 2 0.0089
25 MELANOSIS COLI 1 0.0086
26 TINEA VERSICOLOUR 3 0.0083
27 MESOTHELIOMA MALIGNANT 3 0.0081
28 CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME 1 0.0081
29 BURKHOLDERIA TEST POSITIVE 1 0.0081
30 INTENTIONAL PRODUCT MISUSE TO CHILD 1 0.0078
31 PAROTID GLAND ENLARGEMENT 5 0.0077
32 INTRAUTERINE INFECTION 1 0.0074
33 VULVOVAGINAL ERYTHEMA 6 0.0072
34 NEURAL TUBE DEFECT 5 0.0069
35 CLEFT LIP 6 0.0069
36 VULVOVAGINAL RASH 3 0.0068
37 VULVOVAGINAL SWELLING 12 0.0066
38 LIPOSUCTION 1 0.0065
39 CALCULUS URETHRAL 1 0.0065
40 KIDNEY CONGESTION 1 0.0065
41 CREATININE URINE DECREASED 1 0.0063
42 CONFUSIONAL AROUSAL 1 0.0062
43 HAND-EYE COORDINATION IMPAIRED 1 0.0059
44 INTESTINAL HAEMATOMA 1 0.0057
45 JEJUNOSTOMY 1 0.0055
46 APPLICATION SITE INJURY 1 0.0053
47 VULVOVAGINAL INJURY 3 0.0053
48 EPIDURAL INJECTION 1 0.0051
49 GASTROSTOMY TUBE SITE COMPLICATION 1 0.0050
50 MERALGIA PARAESTHETICA 1 0.0047
51 DEAFNESS TRANSITORY 4 0.0047
52 CYTOMEGALOVIRUS TEST POSITIVE 8 0.0045
53 INFUSION SITE PHLEBITIS 1 0.0044
54 VULVOVAGINAL INFLAMMATION 2 0.0043
55 FALSE NEGATIVE INVESTIGATION RESULT 3 0.0043
56 ENVIRONMENTAL EXPOSURE 1 0.0042
57 CORNEAL NEOVASCULARISATION 1 0.0040
58 TINEA CRURIS 2 0.0040
59 HYDRONEPHROSIS 30 0.0040
60 SUPRAPUBIC PAIN 2 0.0039
61 ANAL ATRESIA 2 0.0037
62 STOMA SITE IRRITATION 2 0.0037
63 MORAXELLA INFECTION 1 0.0036
64 COLON CANCER RECURRENT 1 0.0036
65 GENITAL BLISTER 1 0.0036
66 GENITAL PARAESTHESIA 1 0.0034
67 FALLOPIAN TUBE DISORDER 1 0.0034
68 AURICULAR SWELLING 2 0.0033
69 ALLERGY TO VACCINE 1 0.0032
70 CENTRAL SEROUS CHORIORETINOPATHY 2 0.0029
71 CONJUNCTIVITIS BACTERIAL 1 0.0029
72 TONGUE BITING 6 0.0029
73 GENITAL SWELLING 2 0.0029
74 THERAPEUTIC PROCEDURE 4 0.0029
75 MENTAL RETARDATION 1 0.0028
76 VIRAL HAEMORRHAGIC CYSTITIS 2 0.0028
77 CYTOMEGALOVIRUS ENTERITIS 1 0.0028
78 CRYPTORCHISM 3 0.0027
79 CERVICAL POLYP 1 0.0026
80 HYDROURETER 1 0.0026
81 IMPAIRED REASONING 1 0.0026
82 BACTERIAL VAGINOSIS 4 0.0026
83 HUMAN PAPILLOMA VIRUS TEST POSITIVE 1 0.0025
84 CHEMICAL INJURY 2 0.0024
85 FOETAL DISORDER 2 0.0024
86 CORNEAL DYSTROPHY 1 0.0024
87 CONGENITAL CARDIOVASCULAR ANOMALY 2 0.0024
88 ONYCHOMADESIS 10 0.0024
89 MESOTHELIOMA 3 0.0023
90 GENITAL BURNING SENSATION 2 0.0023
91 MOUTH BREATHING 1 0.0023
92 DIVORCED 1 0.0023
93 ANAEMIA MEGALOBLASTIC 1 0.0022
94 GASTRIC FISTULA 1 0.0022
95 FEEDING INTOLERANCE 1 0.0022
96 MATERNAL DRUGS AFFECTING FOETUS 17 0.0022
97 CIRRHOSIS ALCOHOLIC 1 0.0022
98 VAGINAL DISCHARGE 22 0.0022
99 ANAPHYLACTOID SHOCK 1 0.0021
100 HYPERMETROPIA 2 0.0021
101 GASTROSCHISIS 1 0.0021
102 APLASIA 4 0.0020
103 ABORTION THREATENED 1 0.0020
104 KAPOSI'S SARCOMA 1 0.0020
105 EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) 1 0.0020
106 GLARE 1 0.0019
107 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
108 MARITAL PROBLEM 1 0.0019
109 BURSITIS INFECTIVE 1 0.0018
110 INTERTRIGO 1 0.0018
111 MACULE 5 0.0018
112 BODY TINEA 1 0.0018
113 EXPOSURE TO CHEMICAL POLLUTION 3 0.0018
114 BACTERIURIA 1 0.0018
115 CHEMICAL BURN 2 0.0017
116 CORNEAL EPITHELIUM DEFECT 1 0.0017
117 CAMPYLOBACTER GASTROENTERITIS 1 0.0017
118 AORTIC VALVE STENOSIS 3 0.0017
119 APPLICATION SITE DISCOMFORT 3 0.0017
120 FEBRILE CONVULSION 2 0.0016
121 INCORRECT DRUG DOSAGE FORM ADMINISTERED 1 0.0016
122 STOMA SITE ERYTHEMA 3 0.0016
123 BACILLUS INFECTION 1 0.0016
124 CANCER PAIN 4 0.0016
125 ENTEROCOCCUS TEST POSITIVE 1 0.0015
126 COMPULSIONS 1 0.0015
127 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 1 0.0015
128 ANGULAR CHEILITIS 1 0.0014
129 INTERNATIONAL NORMALISED RATIO INCREASED 41 0.0014
130 DERMATITIS DIAPER 1 0.0014
131 CONGENITAL HYDRONEPHROSIS 1 0.0014
132 CYTOMEGALOVIRUS INFECTION 23 0.0014
133 ACCOMMODATION DISORDER 1 0.0014
134 BLUNTED AFFECT 1 0.0014
135 GENITAL PAIN 2 0.0014
136 HEART SOUNDS ABNORMAL 1 0.0013
137 SECONDARY ADRENOCORTICAL INSUFFICIENCY 2 0.0013
138 ENTEROVESICAL FISTULA 1 0.0013
139 ELECTROCARDIOGRAM PR PROLONGATION 1 0.0013
140 CYTOMEGALOVIRUS ENTEROCOLITIS 1 0.0013
141 BREAST FEEDING 1 0.0013
142 ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED 1 0.0013
143 FUNGAEMIA 2 0.0013
144 VULVOVAGINAL MYCOTIC INFECTION 5 0.0013
145 BREAST CALCIFICATIONS 1 0.0013
146 ENDOMETRIAL HYPERPLASIA 1 0.0012
147 BREAST OPERATION 1 0.0012
148 GRANULOMA SKIN 1 0.0012
149 BALANOPOSTHITIS 1 0.0012
150 PATHOLOGICAL GAMBLING 2 0.0012
151 ODYNOPHAGIA 7 0.0012
152 CRANIOSYNOSTOSIS 1 0.0012
153 DERMATITIS ACNEIFORM 7 0.0011
154 PARTIAL SEIZURES 6 0.0011
155 INFUSION SITE DISCOLOURATION 1 0.0011
156 ANOGENITAL WARTS 1 0.0011
157 CATHETER MANAGEMENT 1 0.0011
158 INTESTINAL INFARCTION 1 0.0011
159 STOMA SITE DISCHARGE 3 0.0011
160 CERUMEN IMPACTION 1 0.0011
161 LOBAR PNEUMONIA 2 0.0011
162 HYPERACUSIS 4 0.0011
163 RENAL TUBULAR DISORDER 3 0.0011
164 MICROANGIOPATHY 1 0.0011
165 BLADDER CATHETERISATION 1 0.0010
166 CROSS SENSITIVITY REACTION 1 0.0010
167 LYMPHADENECTOMY 1 0.0010
168 BONE MARROW DEPRESSION 1 0.0010
169 HAEMOPHILUS INFECTION 1 0.0010
170 PYELONEPHRITIS ACUTE 2 0.0010
171 COLON ADENOMA 1 0.0010
172 ERYSIPELAS 5 0.0010
173 BRAIN STEM INFARCTION 1 0.0010
174 ANAPHYLACTOID REACTION 4 0.0010
175 CAROTID ARTERIOSCLEROSIS 1 0.0010
176 VAGINAL HAEMORRHAGE 42 0.0010
177 INFUSION SITE DISCOMFORT 1 0.0010
178 HYPOSPADIAS 2 0.0010
179 FEEDING DISORDER NEONATAL 1 0.0010
180 GALLBLADDER ENLARGEMENT 1 0.0009
181 INFUSION SITE MASS 1 0.0009
182 DRUG EXPOSURE VIA BREAST MILK 1 0.0009
183 BLOOD TESTOSTERONE ABNORMAL 1 0.0009
184 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 1 0.0009
185 CARDIAC HYPERTROPHY 1 0.0009
186 FACIAL PAIN 8 0.0009
187 LYMPHOCYTE COUNT ABNORMAL 1 0.0009
188 EYE MOVEMENT DISORDER 6 0.0009
189 GASTROINTESTINAL BACTERIAL INFECTION 1 0.0009
190 ADMINISTRATION SITE PAIN 1 0.0009
191 APPLICATION SITE PAIN 19 0.0009
192 RALES 5 0.0009
193 SPINAL COLUMN STENOSIS 4 0.0008
194 INGROWING NAIL 2 0.0008
195 HAEMORRHAGE SUBCUTANEOUS 3 0.0008
196 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 1 0.0008
197 DYSFUNCTIONAL UTERINE BLEEDING 1 0.0008
198 RETROPERITONEAL HAEMORRHAGE 2 0.0008
199 FREEZING PHENOMENON 3 0.0008
200 INJECTION SITE ABSCESS 2 0.0008
201 ALLERGY TO CHEMICALS 1 0.0008
202 INTRADUCTAL PROLIFERATIVE BREAST LESION 1 0.0008
203 LIP DISCOLOURATION 1 0.0008
204 EXCORIATION 2 0.0008
205 RESPIRATORY RATE INCREASED 7 0.0008
206 BRONCHIAL SECRETION RETENTION 1 0.0008
207 LEFT ATRIAL DILATATION 1 0.0008
208 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
209 MICROCEPHALY 1 0.0008
210 LIP DRY 7 0.0008
211 ADJUSTMENT DISORDER 1 0.0008
212 COUNTERFEIT PRODUCT ADMINISTERED 1 0.0008
213 GASTROENTERITIS NOROVIRUS 1 0.0008
214 OESOPHAGEAL CANDIDIASIS 3 0.0008
215 CORNEAL OPACITY 1 0.0007
216 BLOOD PHOSPHORUS INCREASED 2 0.0007
217 APPLICATION SITE HAEMORRHAGE 2 0.0007
218 SUBDURAL HAEMORRHAGE 2 0.0007
219 INFUSION SITE RASH 1 0.0007
220 CULTURE URINE POSITIVE 1 0.0007
221 ANTIPSYCHOTIC DRUG LEVEL INCREASED 2 0.0007
222 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
223 GENITAL RASH 1 0.0007
224 SALIVARY HYPERSECRETION 7 0.0007
225 INVESTIGATION ABNORMAL 1 0.0007
226 CARDIAC MURMUR 6 0.0007
227 TOOTH ABSCESS 7 0.0007
228 SPINAL OSTEOARTHRITIS 6 0.0007
229 GENERALISED ANXIETY DISORDER 1 0.0007
230 GROWTH RETARDATION 2 0.0007
231 APRAXIA 1 0.0007
232 INTERCEPTED DRUG DISPENSING ERROR 1 0.0007
233 INFERTILITY 1 0.0007
234 EPICONDYLITIS 1 0.0007
235 GENITAL HERPES 1 0.0007
236 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
237 CUSHINGOID 2 0.0006
238 BLOOD CALCIUM DECREASED 7 0.0006
239 DISINHIBITION 1 0.0006
240 SKIN EROSION 2 0.0006
241 DENTAL IMPLANTATION 1 0.0006
242 TOOTH INFECTION 8 0.0006
243 EXPIRED DRUG ADMINISTERED 3 0.0006
244 NEAR DEATH EXPERIENCE 2 0.0006
245 ORGANISING PNEUMONIA 3 0.0006
246 ILLUSION 1 0.0006
247 SKIN INJURY 2 0.0006
248 HEPATORENAL SYNDROME 1 0.0006
249 AMMONIA INCREASED 3 0.0006
250 ECCHYMOSIS 4 0.0006
251 MILIARIA 1 0.0006
252 APLASIA PURE RED CELL 2 0.0006
253 ORAL DISCOMFORT 8 0.0006
254 MENINGITIS CRYPTOCOCCAL 1 0.0006
255 PRODUCT CONTAMINATION 2 0.0006
256 BLOOD CREATININE INCREASED 36 0.0006
257 BODY TEMPERATURE ABNORMAL 1 0.0005
258 BLINDNESS TRANSIENT 4 0.0005
259 ON AND OFF PHENOMENON 3 0.0005
260 FEELING DRUNK 4 0.0005
261 BLADDER SPASM 1 0.0005
262 IMPULSIVE BEHAVIOUR 2 0.0005
263 HYPOPROTEINAEMIA 1 0.0005
264 FACE INJURY 2 0.0005
265 PRODUCT PACKAGING ISSUE 5 0.0005
266 INTENTIONAL MISUSE 1 0.0005
267 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
268 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
269 SKIN ATROPHY 3 0.0005
270 CUTANEOUS LUPUS ERYTHEMATOSUS 1 0.0005
271 PELVIC FRACTURE 4 0.0005
272 SKIN FISSURES 10 0.0005
273 COLOSTOMY 1 0.0005
274 CANDIDIASIS 2 0.0005
275 OBSESSIVE-COMPULSIVE DISORDER 4 0.0005
276 FUNGAL SKIN INFECTION 2 0.0005
277 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 3 0.0005
278 APPLICATION SITE PRURITUS 11 0.0005
279 ATRIAL THROMBOSIS 1 0.0005
280 TOOTH LOSS 10 0.0005
281 ANAL PRURITUS 1 0.0005
282 ACCIDENTAL EXPOSURE 2 0.0005
283 HEPATIC NEOPLASM MALIGNANT 1 0.0005
284 SKIN HAEMORRHAGE 7 0.0005
285 FEBRILE BONE MARROW APLASIA 2 0.0005
286 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
287 APPLICATION SITE SCAB 1 0.0005
288 INFUSION SITE BRUISING 1 0.0005
289 INCORRECT PRODUCT ADMINISTRATION DURATION 10 0.0005
290 BIPOLAR I DISORDER 1 0.0005
291 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
292 DEVICE RELATED INFECTION 7 0.0005
293 GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0005
294 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
295 RHINITIS ALLERGIC 2 0.0004
296 BASAL CELL CARCINOMA 7 0.0004
297 SUSPECTED OFF LABEL USE 2 0.0004
298 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
299 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
300 INFUSION SITE INFECTION 1 0.0004
301 MOUTH ULCERATION 9 0.0004
302 VAGINAL INFECTION 2 0.0004
303 TONGUE DISORDER 3 0.0004
304 CANDIDA INFECTION 7 0.0004
305 LYMPHADENITIS 1 0.0004
306 APPLICATION SITE BURN 2 0.0004
307 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
308 HYPERNATRAEMIA 2 0.0004
309 CATHETER SITE HAEMORRHAGE 1 0.0004
310 BRAIN ABSCESS 1 0.0004
311 CHEMICAL BURN OF SKIN 1 0.0004
312 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 2 0.0004
313 DIABETIC COMPLICATION 1 0.0004
314 PHARYNGEAL OEDEMA 6 0.0004
315 MEAN CELL VOLUME INCREASED 1 0.0004
316 APNOEA 3 0.0004
317 PULMONARY HAEMORRHAGE 3 0.0004
318 AGRANULOCYTOSIS 7 0.0004
319 ANGIONEUROTIC OEDEMA 1 0.0004
320 HYPERLACTACIDAEMIA 1 0.0004
321 BREAST CANCER METASTATIC 4 0.0004
322 GAMBLING DISORDER 1 0.0004
323 ABDOMINAL RIGIDITY 1 0.0004
324 SEPSIS 41 0.0004
325 HYDROCEPHALUS 2 0.0004
326 DRUG INTERACTION 58 0.0004
327 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
328 HEART RATE ABNORMAL 2 0.0004
329 PRODUCT LEAKAGE 2 0.0004
330 ACUTE PULMONARY OEDEMA 2 0.0004
331 PAIN IN JAW 10 0.0004
332 LIP PAIN 1 0.0003
333 HERPES VIRUS INFECTION 2 0.0003
334 FIBULA FRACTURE 1 0.0003
335 ADENOVIRUS INFECTION 1 0.0003
336 LUMBAR SPINAL STENOSIS 1 0.0003
337 URINE ODOUR ABNORMAL 2 0.0003
338 CATARACT OPERATION 2 0.0003
339 MUSCLE RIGIDITY 4 0.0003
340 BLOOD CULTURE POSITIVE 1 0.0003
341 HIV INFECTION 1 0.0003
342 LOSS OF EMPLOYMENT 1 0.0003
343 FOETAL GROWTH RESTRICTION 2 0.0003
344 KERATITIS 1 0.0003
345 DYSCHEZIA 1 0.0003
346 DIABETIC FOOT 1 0.0003
347 UROSEPSIS 3 0.0003
348 DIASTOLIC DYSFUNCTION 1 0.0003
349 ANKLE FRACTURE 5 0.0003
350 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
351 APPLICATION SITE IRRITATION 4 0.0003
352 INCORRECT DRUG ADMINISTRATION DURATION 9 0.0003
353 INFUSION SITE PRURITUS 1 0.0003
354 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
355 SLEEP APNOEA SYNDROME 6 0.0003
356 BURNING SENSATION 22 0.0003
357 WHITE BLOOD CELL COUNT ABNORMAL 2 0.0003
358 GLOSSODYNIA 7 0.0003
359 CHOLESTASIS 6 0.0003
360 ROTATOR CUFF SYNDROME 4 0.0003
361 LOOSE TOOTH 1 0.0003
362 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0003
363 BACTERIAL SEPSIS 1 0.0003
364 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
365 POLYP 2 0.0003
366 ANHEDONIA 8 0.0003
367 INFUSION SITE HAEMORRHAGE 1 0.0003
368 STAPHYLOCOCCAL INFECTION 10 0.0003
369 CYTOLYTIC HEPATITIS 1 0.0003
370 DYSURIA 11 0.0003
371 POST-TRAUMATIC STRESS DISORDER 2 0.0003
372 TOXIC SKIN ERUPTION 3 0.0003
373 B-CELL LYMPHOMA 1 0.0003
374 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
375 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
376 BLOOD CREATININE ABNORMAL 1 0.0003
377 MICTURITION DISORDER 1 0.0003
378 UNDERDOSE 21 0.0003
379 PETECHIAE 3 0.0003
380 PRODUCT ODOUR ABNORMAL 3 0.0003
381 DERMATITIS 6 0.0003
382 CARPAL TUNNEL SYNDROME 4 0.0003
383 RIGHT VENTRICULAR FAILURE 2 0.0003
384 SCRATCH 3 0.0003
385 HEART DISEASE CONGENITAL 1 0.0003
386 THERMAL BURN 2 0.0003
387 GLOSSITIS 1 0.0003
388 FIBRIN D DIMER INCREASED 1 0.0003
389 HAEMORRHAGIC DIATHESIS 1 0.0003
390 CONJUNCTIVAL HYPERAEMIA 1 0.0003
391 MONOCYTE COUNT INCREASED 1 0.0003
392 BLOOD PHOSPHORUS DECREASED 1 0.0003
393 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0003
394 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5 0.0003
395 MOUTH HAEMORRHAGE 2 0.0003
396 SENSITIVE SKIN 2 0.0003
397 HAEMATOMA 7 0.0003
398 ARTHROPOD BITE 2 0.0003
399 JOINT STIFFNESS 7 0.0003
400 MATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0003
401 STATUS EPILEPTICUS 3 0.0003
402 OSTEOPENIA 4 0.0003
403 DERMATITIS CONTACT 3 0.0003
404 INCREASED APPETITE 5 0.0003
405 BOWEL MOVEMENT IRREGULARITY 2 0.0003
406 CARDIOPULMONARY FAILURE 1 0.0003
407 CEREBRAL ATROPHY 1 0.0003
408 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
409 ASPHYXIA 2 0.0002
410 HYPERURICAEMIA 1 0.0002
411 FUNGAL INFECTION 8 0.0002
412 ABDOMINAL PAIN LOWER 6 0.0002
413 CONDITION AGGRAVATED 72 0.0002
414 HEPATIC CYTOLYSIS 3 0.0002
415 HAEMATURIA 8 0.0002
416 PYELONEPHRITIS 2 0.0002
417 SKIN SWELLING 2 0.0002
418 CHAPPED LIPS 1 0.0002
419 ORTHOSTATIC HYPOTENSION 4 0.0002
420 IMMOBILE 1 0.0002
421 MELANOCYTIC NAEVUS 1 0.0002
422 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
423 STEVENS-JOHNSON SYNDROME 5 0.0002
424 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
425 IMPAIRED GASTRIC EMPTYING 3 0.0002
426 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
427 LUMBAR VERTEBRAL FRACTURE 1 0.0002
428 IRON DEFICIENCY ANAEMIA 2 0.0002
429 LOCALISED OEDEMA 1 0.0002
430 FLANK PAIN 2 0.0002
431 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
432 BLOOD URINE PRESENT 4 0.0002
433 HYPERSENSITIVITY 39 0.0002
434 FEELING JITTERY 4 0.0002
435 GESTATIONAL DIABETES 1 0.0002
436 GASTROINTESTINAL TOXICITY 1 0.0002
437 HUMERUS FRACTURE 1 0.0002
438 HYPERTHYROIDISM 3 0.0002
439 FLUID OVERLOAD 3 0.0002
440 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
441 INFLAMMATORY BOWEL DISEASE 2 0.0002
442 CONSTIPATION 44 0.0002
443 INFLAMMATORY MARKER INCREASED 1 0.0002
444 ABDOMINAL TENDERNESS 1 0.0002
445 IMMUNODEFICIENCY 3 0.0002
446 INJECTION SITE INFLAMMATION 1 0.0002
447 APPLICATION SITE SWELLING 1 0.0002
448 HAEMORRHAGE INTRACRANIAL 3 0.0002
449 FLUID INTAKE REDUCED 1 0.0002
450 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
451 PERITONITIS BACTERIAL 2 0.0002
452 ECONOMIC PROBLEM 3 0.0002
453 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
454 SLUGGISHNESS 2 0.0002
455 CEREBRAL ISCHAEMIA 1 0.0002
456 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
457 DELUSION 3 0.0002
458 FAILURE TO THRIVE 1 0.0002
459 ACUTE MYELOID LEUKAEMIA 3 0.0002
460 MUCOSAL INFLAMMATION 5 0.0002
461 CATATONIA 1 0.0002
462 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
463 IRRITABLE BOWEL SYNDROME 4 0.0002
464 ANAL FISSURE 1 0.0002
465 HEREDITARY ANGIOEDEMA 2 0.0002
466 ABDOMINAL PAIN 43 0.0002
467 CHEILITIS 1 0.0002
468 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
469 METASTASES TO BONE 3 0.0002
470 MULTIPLE FRACTURES 3 0.0002
471 JAW DISORDER 1 0.0002
472 FAECALOMA 1 0.0002
473 ASTHENOPIA 1 0.0002
474 CHOKING SENSATION 1 0.0002
475 EXPIRED PRODUCT ADMINISTERED 6 0.0002
476 FOOT DEFORMITY 2 0.0002
477 FACE OEDEMA 3 0.0002
478 COLECTOMY 1 0.0002
479 MYOCARDIAL ISCHAEMIA 2 0.0002
480 GRANULOCYTOPENIA 1 0.0002
481 SCAB 2 0.0002
482 SCAR 3 0.0002
483 MICTURITION URGENCY 2 0.0002
484 HYPERTONIA 1 0.0002
485 MYOCARDITIS 2 0.0002
486 EXERCISE TOLERANCE DECREASED 1 0.0002
487 MOUTH SWELLING 1 0.0002
488 BLOOD URIC ACID INCREASED 1 0.0002
489 LOCAL SWELLING 3 0.0002
490 HYPOVOLAEMIA 1 0.0002
491 OSTEOPOROSIS 7 0.0002
492 ENERGY INCREASED 1 0.0002
493 BRADYKINESIA 1 0.0002
494 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
495 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
496 GANGRENE 1 0.0002
497 APHASIA 5 0.0002
498 RENAL FAILURE ACUTE 7 0.0002
499 BURSITIS 2 0.0002
500 ADRENAL INSUFFICIENCY 2 0.0002
501 END STAGE RENAL DISEASE 3 0.0002
502 RESPIRATORY DEPRESSION 2 0.0002
503 ENCEPHALOPATHY 4 0.0002
504 CARDIOMEGALY 2 0.0002
505 LARYNGEAL OEDEMA 1 0.0002
506 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
507 CONJUNCTIVITIS 3 0.0002
508 GENERALISED OEDEMA 2 0.0002
509 PHARYNGITIS 2 0.0002
510 INFUSION SITE EXTRAVASATION 1 0.0002
511 URINARY TRACT INFECTION 27 0.0002
512 NEUROPATHY PERIPHERAL 15 0.0002
513 CYSTITIS 5 0.0002
514 PULMONARY FIBROSIS 3 0.0002
515 PRODUCT SUBSTITUTION ISSUE 9 0.0002
516 ENTERITIS 1 0.0002
517 ACUTE RESPIRATORY FAILURE 3 0.0002
518 ANGINA UNSTABLE 1 0.0002
519 HERPES SIMPLEX 1 0.0002
520 DEAFNESS 4 0.0002
521 DYSGRAPHIA 1 0.0002
522 ADVERSE REACTION 2 0.0002
523 MENINGITIS 1 0.0001
524 SWELLING 14 0.0001
525 CYTOKINE RELEASE SYNDROME 3 0.0001
526 BREAST MASS 1 0.0001
527 BONE MARROW FAILURE 3 0.0001
528 DISCOMFORT 9 0.0001
529 DRUG EXPOSURE DURING PREGNANCY 5 0.0001
530 CHRONIC KIDNEY DISEASE 11 0.0001
531 LYMPHOEDEMA 1 0.0001
532 INTERSTITIAL LUNG DISEASE 7 0.0001
533 PRODUCT USE ISSUE 27 0.0001
534 INTENTIONAL DRUG MISUSE 3 0.0001
535 LUNG DISORDER 7 0.0001
536 BLISTER 8 0.0001
537 DUODENAL ULCER 1 0.0001
538 OSTEOARTHRITIS 6 0.0001
539 SEASONAL ALLERGY 2 0.0001
540 DIVERTICULUM 1 0.0001
541 BRONCHOSPASM 2 0.0001
542 CELLULITIS 7 0.0001
543 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
544 SWELLING FACE 9 0.0001
545 DERMATITIS BULLOUS 1 0.0001
546 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
547 RESPIRATORY FAILURE 10 0.0001
548 GASTROENTERITIS 2 0.0001
549 MAJOR DEPRESSION 1 0.0001
550 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
551 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
552 RASH MACULO-PAPULAR 3 0.0001
553 EYE SWELLING 5 0.0001
554 PULMONARY MASS 2 0.0001
555 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
556 LIPASE INCREASED 1 0.0001
557 ATRIOVENTRICULAR BLOCK 1 0.0001
558 COGNITIVE DISORDER 6 0.0001
559 BONE DENSITY DECREASED 4 0.0001
560 GASTROINTESTINAL INFLAMMATION 1 0.0001
561 AFFECTIVE DISORDER 1 0.0001
562 PRODUCT USE COMPLAINT 2 0.0001
563 FURUNCLE 1 0.0001
564 BLOOD ALBUMIN DECREASED 1 0.0001
565 ULCER 2 0.0001
566 OBESITY 2 0.0001
567 SCIATICA 2 0.0001
568 PANCYTOPENIA 7 0.0001
569 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
570 DIABETIC KETOACIDOSIS 3 0.0001
571 MIOSIS 1 0.0001
572 DYSKINESIA 5 0.0001
573 DECUBITUS ULCER 1 0.0001
574 HICCUPS 1 0.0001
575 HAIR DISORDER 1 0.0001
576 DRY EYE 6 0.0001
577 PNEUMONIA ASPIRATION 3 0.0001
578 POLLAKIURIA 5 0.0001
579 HAEMODIALYSIS 1 0.0001
580 INFUSION SITE ERYTHEMA 1 0.0001
581 CARDIAC OPERATION 1 0.0001
582 SKIN ULCER 3 0.0001
583 MULTI-ORGAN FAILURE 2 0.0001
584 HYSTERECTOMY 1 0.0001
585 EOSINOPHILIA 2 0.0001
586 BLOOD CALCIUM INCREASED 1 0.0001
587 GRIP STRENGTH DECREASED 1 0.0001
588 LYMPHOCYTE COUNT DECREASED 2 0.0001
589 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
590 DRUG INEFFECTIVE 148 0.0001
591 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
592 HAEMOLYTIC ANAEMIA 1 0.0001
593 HAEMARTHROSIS 1 0.0001
594 GASTROINTESTINAL INFECTION 1 0.0001
595 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
596 HEAVY MENSTRUAL BLEEDING 1 0.0001
597 LUPUS-LIKE SYNDROME 1 0.0001
598 PELVIC PAIN 2 0.0001
599 SKIN IRRITATION 5 0.0001
600 PRODUCT USE IN UNAPPROVED INDICATION 27 0.0001
601 INCREASED TENDENCY TO BRUISE 1 0.0001
602 HYPOKALAEMIA 5 0.0001
603 GRAND MAL CONVULSION 1 0.0001
604 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
605 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
606 HAEMOPTYSIS 3 0.0001
607 HEPATIC STEATOSIS 2 0.0001
608 BACTERIAL INFECTION 2 0.0001
609 APPENDICITIS 1 0.0001
610 ERYTHEMA 22 0.0001
611 DEFORMITY 1 0.0001
612 OEDEMA PERIPHERAL 13 0.0001
613 LACERATION 1 0.0001
614 ABORTION INDUCED 1 0.0001
615 FOOT FRACTURE 2 0.0001
616 DYSPHAGIA 10 0.0001
617 COMA 5 0.0001
618 DIABETES MELLITUS 8 0.0001
619 RASH ERYTHEMATOUS 5 0.0001
620 HERPES ZOSTER 6 0.0001
621 DRUG PRESCRIBING ERROR 2 0.0001
622 DIZZINESS POSTURAL 1 0.0001
623 HEPATOMEGALY 1 0.0001
624 KNEE OPERATION 1 0.0001
625 URINARY INCONTINENCE 3 0.0001
626 HOSPICE CARE 1 0.0001
627 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
628 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
629 RENAL INJURY 3 0.0001
630 SINUS DISORDER 2 0.0001
631 HAEMATOCRIT DECREASED 2 0.0001
632 INABILITY TO AFFORD MEDICATION 1 0.0001
633 UPPER LIMB FRACTURE 2 0.0001
634 BRAIN INJURY 1 0.0001
635 HYPOTHERMIA 1 0.0001
636 EYELID PTOSIS 1 0.0001
637 NEUTROPHIL COUNT DECREASED 4 0.0001
638 MOTOR DYSFUNCTION 1 0.0001
639 BODY TEMPERATURE INCREASED 2 0.0001
640 ACUTE KIDNEY INJURY 15 0.0001
641 RENAL FAILURE 13 0.0001
642 DRUG ADMINISTRATION ERROR 3 0.0001
643 HELICOBACTER INFECTION 1 0.0001
644 RIB FRACTURE 2 0.0001
645 EXPOSURE DURING PREGNANCY 6 0.0001
646 ROAD TRAFFIC ACCIDENT 4 0.0001
647 SPEECH DISORDER 5 0.0001
648 SEIZURE 11 0.0001
649 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
650 HALLUCINATION, VISUAL 2 0.0001
651 JOINT DISLOCATION 1 0.0001
652 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
653 WEIGHT DECREASED 26 0.0001
654 CONFUSIONAL STATE 15 0.0001
655 BALANCE DISORDER 8 0.0001
656 BIPOLAR DISORDER 1 0.0001
657 MENTAL DISORDER 4 0.0001
658 ASPIRATION 1 0.0001
659 BLOOD GLUCOSE FLUCTUATION 1 0.0001
660 EYE DISORDER 3 0.0001
661 MELAENA 2 0.0001
662 ANAPHYLACTIC REACTION 5 0.0001
663 FEBRILE NEUTROPENIA 6 0.0001
664 BLOOD PRESSURE DECREASED 6 0.0001
665 SYNCOPE 9 0.0001
666 PULMONARY OEDEMA 4 0.0001
667 ANAEMIA 17 0.0001
668 INTESTINAL PERFORATION 1 0.0001
669 CHROMATURIA 2 0.0001
670 ASTHMA 10 0.0001
671 HEPATIC ENZYME INCREASED 6 0.0001
672 IMPAIRED DRIVING ABILITY 1 0.0001
673 ANXIETY 25 0.0001
674 PRODUCT AVAILABILITY ISSUE 2 0.0001
675 HAEMOGLOBIN DECREASED 9 0.0001
676 CARDIAC FAILURE 7 0.0001
677 SKIN DISCOLOURATION 4 0.0001
678 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
679 METASTASES TO LUNG 1 0.0001
680 PERICARDIAL EFFUSION 2 0.0001
681 DELIRIUM 3 0.0001
682 EYELID OEDEMA 1 0.0001
683 PRURITUS 33 0.0001
684 RENAL DISORDER 4 0.0001
685 CARDIAC DISORDER 8 0.0001
686 HYPOXIA 3 0.0001
687 OCULAR HYPERAEMIA 4 0.0001
688 BACTERAEMIA 1 0.0001
689 ACCIDENT 1 0.0001
690 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
691 RENAL IMPAIRMENT 7 0.0001
692 CONTUSION 8 0.0001
693 CRYING 3 0.0001
694 HYPOGLYCAEMIA 4 0.0001
695 C-REACTIVE PROTEIN INCREASED 3 0.0001
696 STOMATITIS 5 0.0001
697 PRESYNCOPE 2 0.0001
698 ATRIAL FIBRILLATION 8 0.0001
699 RESTLESSNESS 3 0.0001
700 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
701 OSTEONECROSIS OF JAW 2 0.0001
702 ILEUS 1 0.0001
703 HEPATIC FUNCTION ABNORMAL 3 0.0001
704 CARDIOVASCULAR DISORDER 2 0.0001
705 HYPOPHAGIA 2 0.0001
706 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
707 ERECTILE DYSFUNCTION 2 0.0001
708 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
709 INFUSION SITE PAIN 1 0.0001
710 URTICARIA 13 0.0001
711 ANOREXIA 1 0.0001
712 HIATUS HERNIA 1 0.0001
713 INJECTION SITE INDURATION 1 0.0001
714 RESPIRATORY TRACT INFECTION 2 0.0001
715 SEDATION 2 0.0001
716 GASTRITIS 2 0.0001
717 IMMUNE SYSTEM DISORDER 1 0.0001
718 ANKYLOSING SPONDYLITIS 1 0.0001
719 DYSMENORRHOEA 1 0.0001
720 EAR INFECTION 2 0.0001
721 DEHYDRATION 10 0.0001
722 EYE HAEMORRHAGE 1 0.0001
723 ABORTION SPONTANEOUS 3 0.0001
724 JOINT RANGE OF MOTION DECREASED 1 0.0001
725 EMOTIONAL DISTRESS 9 0.0001
726 DIZZINESS 37 0.0001
727 PULMONARY EMBOLISM 7 0.0001
728 PNEUMONITIS 2 0.0001
729 DRUG TOXICITY 1 0.0001
730 RASH 32 0.0001
731 GINGIVAL BLEEDING 1 0.0001
732 CORONARY ARTERY OCCLUSION 1 0.0001
733 MENTAL STATUS CHANGES 2 0.0001
734 COORDINATION ABNORMAL 1 0.0001
735 DEMENTIA 2 0.0001
736 WOUND 2 0.0001
737 OXYGEN SATURATION DECREASED 4 0.0001
738 BLOOD TEST ABNORMAL 1 0.0001
739 LYMPHOPENIA 1 0.0001
740 FLATULENCE 4 0.0001
741 DIALYSIS 1 0.0001
742 RED BLOOD CELL COUNT DECREASED 2 0.0001
743 RECTAL HAEMORRHAGE 3 0.0001
744 SKIN BURNING SENSATION 5 0.0001
745 CARDIOGENIC SHOCK 1 0.0001
746 DEVICE DISLOCATION 3 0.0001
747 SEPTIC SHOCK 3 0.0001
748 BACK PAIN 16 0.0001
749 APATHY 1 0.0001
750 OFF LABEL USE 60 0.0001
751 LIVER DISORDER 3 0.0001
752 TACHYCARDIA 6 0.0001
753 RESPIRATORY DISORDER 2 0.0001
754 EPISTAXIS 5 0.0001
755 BONE LOSS 1 0.0001
756 HEPATIC FAILURE 2 0.0001
757 LACRIMATION INCREASED 2 0.0001
758 UNEVALUABLE EVENT 5 0.0001
759 PLEURAL EFFUSION 4 0.0001
760 VERTIGO 4 0.0001
761 VISION BLURRED 9 0.0001
762 NEPHROLITHIASIS 3 0.0001
763 INSURANCE ISSUE 1 0.0001
764 EJECTION FRACTION DECREASED 1 0.0001
765 SWOLLEN TONGUE 2 0.0001
766 BRAIN FOG 1 0.0001
767 CYANOSIS 1 0.0001
768 ARTHRITIS 5 0.0001
769 PAIN 39 0.0001
770 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
771 HALLUCINATION, AUDITORY 1 0.0001
772 PRODUCTIVE COUGH 3 0.0001
773 ABSCESS 1 0.0001
774 THROMBOCYTOPENIA 7 0.0001
775 LOSS OF CONSCIOUSNESS 8 0.0001
776 MOVEMENT DISORDER 2 0.0001
777 INFECTION 9 0.0001
778 DYSPNOEA 35 0.0001
779 DRY MOUTH 5 0.0001
780 BLOOD POTASSIUM INCREASED 1 0.0001
781 DEPRESSION 14 0.0001
782 HYPERTENSION 13 0.0001
783 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001
784 IMPAIRED HEALING 2 0.0001
785 MANIA 1 0.0001
786 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
787 DRUG LEVEL INCREASED 1 0.0001
788 OVERDOSE 13 0.0001
789 LIP SWELLING 2 0.0001
790 SKIN DISORDER 2 0.0001
791 MUSCLE SPASMS 11 0.0001
792 URINARY RETENTION 2 0.0001
793 DRY SKIN 8 0.0001
794 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
795 SKIN EXFOLIATION 5 0.0001
796 PNEUMONIA 19 0.0001
797 METRORRHAGIA 1 0.0001
798 CHEST DISCOMFORT 6 0.0001
799 SINUSITIS 6 0.0001
800 FEELING ABNORMAL 14 0.0001
801 PYREXIA 20 0.0001
802 NIGHTMARE 2 0.0001
803 DEVICE DEFECTIVE 1 0.0001
804 GAIT DISTURBANCE 11 0.0001
805 HAEMORRHAGE 6 0.0001
806 HYPERKALAEMIA 2 0.0001
807 COVID-19 10 0.0001
808 HEART RATE DECREASED 2 0.0001
809 INJURY 4 0.0001
810 SLEEP DISORDER 4 0.0001
811 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
812 HEAD DISCOMFORT 1 0.0001
813 DRUG ERUPTION 1 0.0001
814 GALLBLADDER DISORDER 1 0.0001
815 CEREBRAL HAEMORRHAGE 2 0.0001
816 ADVERSE DRUG REACTION 5 0.0001
817 DISTURBANCE IN ATTENTION 3 0.0001
818 GASTROENTERITIS VIRAL 1 0.0001
819 HYPERGLYCAEMIA 2 0.0001
820 ACCIDENTAL OVERDOSE 2 0.0001
821 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
822 SOMNOLENCE 11 0.0001
823 AGITATION 4 0.0001
824 PAIN IN EXTREMITY 16 0.0001
825 INFLUENZA 6 0.0001
826 HYPONATRAEMIA 3 0.0001
827 BLOOD SODIUM DECREASED 1 0.0001
828 ARTHRALGIA 22 0.0001
829 HYPOCALCAEMIA 1 0.0001
830 MUSCULAR WEAKNESS 6 0.0001
831 COLITIS 2 0.0001
832 GASTRIC ULCER 1 0.0001
833 CONVULSION 3 0.0001
834 MIGRAINE 5 0.0001
835 PERIPHERAL SWELLING 8 0.0001
836 GLAUCOMA 1 0.0001
837 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
838 DRUG INTOLERANCE 5 0.0001
839 HERNIA 1 0.0001
840 DYSTONIA 1 0.0001
841 HAEMORRHOIDS 1 0.0001
842 CHILLS 6 0.0001
843 SURGERY 3 0.0001
844 KIDNEY INFECTION 1 0.0001
845 ALOPECIA 10 0.0001
846 HEART RATE INCREASED 5 0.0001
847 BLOOD PRESSURE ABNORMAL 1 0.0001
848 CARDIAC FAILURE CONGESTIVE 4 0.0000
849 ILL-DEFINED DISORDER 3 0.0000
850 FEEDING DISORDER 1 0.0000
851 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
852 INJECTION SITE WARMTH 1 0.0000
853 ILLNESS 5 0.0000
854 TREATMENT FAILURE 4 0.0000
855 MALAISE 21 0.0000
856 EATING DISORDER 1 0.0000
857 PLATELET COUNT DECREASED 5 0.0000
858 IMPAIRED WORK ABILITY 1 0.0000
859 DIARRHOEA 30 0.0000
860 HYPOACUSIS 2 0.0000
861 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
862 AMNESIA 3 0.0000
863 BLOOD PRESSURE INCREASED 7 0.0000
864 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
865 HOSPITALISATION 7 0.0000
866 INFUSION RELATED REACTION 3 0.0000
867 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
868 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
869 HEART RATE IRREGULAR 1 0.0000
870 RHEUMATOID ARTHRITIS 5 0.0000
871 SUICIDAL IDEATION 4 0.0000
872 MEMORY IMPAIRMENT 6 0.0000
873 TINNITUS 2 0.0000
874 ADVERSE EVENT 4 0.0000
875 CHEST PAIN 8 0.0000
876 ARRHYTHMIA 2 0.0000
877 TREMOR 7 0.0000
878 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
879 BLOOD PRESSURE FLUCTUATION 1 0.0000
880 LOCALISED INFECTION 1 0.0000
881 CEREBROVASCULAR ACCIDENT 7 0.0000
882 INSOMNIA 11 0.0000
883 MENTAL IMPAIRMENT 1 0.0000
884 CEREBRAL INFARCTION 1 0.0000
885 PRODUCT DOSE OMISSION ISSUE 12 0.0000
886 ABASIA 1 0.0000
887 DYSGEUSIA 3 0.0000
888 VISUAL IMPAIRMENT 5 0.0000
889 LEUKOPENIA 2 0.0000
890 HALLUCINATION 3 0.0000
891 FLUID RETENTION 2 0.0000
892 COUGH 11 0.0000
893 HEPATITIS 1 0.0000
894 DRUG RESISTANCE 1 0.0000
895 ABDOMINAL PAIN UPPER 8 0.0000
896 ANAPHYLACTIC SHOCK 1 0.0000
897 ABDOMINAL DISTENSION 4 0.0000
898 ECZEMA 2 0.0000
899 BREAST CANCER FEMALE 1 0.0000
900 JAUNDICE 1 0.0000
901 BLOOD BILIRUBIN INCREASED 1 0.0000
902 RASH PRURITIC 2 0.0000
903 OEDEMA 2 0.0000
904 NEUTROPENIA 5 0.0000
905 TREATMENT NONCOMPLIANCE 2 0.0000
906 ABNORMAL DREAMS 1 0.0000
907 ARTHROPATHY 2 0.0000
908 MEDICATION ERROR 2 0.0000
909 FEELING COLD 1 0.0000
910 ABDOMINAL DISCOMFORT 6 0.0000
911 INTENTIONAL DOSE OMISSION 1 0.0000
912 ANGINA PECTORIS 1 0.0000
913 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
914 LIVER FUNCTION TEST ABNORMAL 1 0.0000
915 DYSSTASIA 1 0.0000
916 PALPITATIONS 4 0.0000
917 BONE PAIN 2 0.0000
918 LABORATORY TEST ABNORMAL 1 0.0000
919 CATARACT 2 0.0000
920 GASTROINTESTINAL DISORDER 3 0.0000
921 HYPOAESTHESIA 5 0.0000
922 BLOOD POTASSIUM DECREASED 1 0.0000
923 NO ADVERSE EVENT 6 0.0000
924 FALL 11 0.0000
925 FEELING HOT 2 0.0000
926 INJECTION SITE RASH 1 0.0000
927 GYNAECOMASTIA 1 0.0000
928 FEMUR FRACTURE 1 0.0000
929 ASTHENIA 12 0.0000
930 HEADACHE 20 0.0000
931 WEIGHT INCREASED 7 0.0000
932 DECREASED APPETITE 7 0.0000
933 NEOPLASM MALIGNANT 2 0.0000
934 GAIT INABILITY 1 0.0000
935 VOMITING 14 0.0000
936 EYE PRURITUS 1 0.0000
937 GASTRIC DISORDER 1 0.0000
938 NAUSEA 23 0.0000
939 LYMPHADENOPATHY 1 0.0000
940 THERAPY INTERRUPTED 2 0.0000
941 INJECTION SITE MASS 1 0.0000
942 DYSARTHRIA 1 0.0000
943 INJECTION SITE SWELLING 2 0.0000
944 DEATH 22 0.0000
945 DISEASE PROGRESSION 3 0.0000
946 ABNORMAL BEHAVIOUR 1 0.0000
947 DISORIENTATION 1 0.0000
948 HYPOTENSION 5 0.0000
949 THROMBOSIS 2 0.0000
950 FATIGUE 19 0.0000
951 LUNG NEOPLASM MALIGNANT 1 0.0000
952 INFLUENZA LIKE ILLNESS 2 0.0000
953 INJECTION SITE ERYTHEMA 3 0.0000
954 COMPLETED SUICIDE 2 0.0000
955 CARDIO-RESPIRATORY ARREST 1 0.0000
956 MYALGIA 4 0.0000
957 DEVICE LEAKAGE 1 0.0000
958 INTENTIONAL PRODUCT MISUSE 2 0.0000
959 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
960 ANGIOEDEMA 1 0.0000
961 COLITIS ULCERATIVE 1 0.0000
962 DEVICE ISSUE 2 0.0000
963 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
964 NASOPHARYNGITIS 4 0.0000
965 OROPHARYNGEAL PAIN 2 0.0000
966 BREAST CANCER 2 0.0000
967 BLOOD GLUCOSE DECREASED 1 0.0000
968 DYSPEPSIA 2 0.0000
969 AGGRESSION 1 0.0000
970 FLUSHING 2 0.0000
971 INFLAMMATION 1 0.0000
972 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
973 DERMATITIS ATOPIC 1 0.0000
974 DRUG DEPENDENCE 3 0.0000
975 DRUG EFFECT DECREASED 1 0.0000
976 DRUG DOSE OMISSION 3 0.0000
977 HAEMATOCHEZIA 1 0.0000
978 TOXICITY TO VARIOUS AGENTS 3 0.0000
979 EYE PAIN 1 0.0000
980 INCORRECT DOSE ADMINISTERED 4 0.0000
981 LETHARGY 1 0.0000
982 EYE IRRITATION 1 0.0000
983 IRRITABILITY 1 0.0000
984 JOINT SWELLING 2 0.0000
985 INJECTION SITE PAIN 5 0.0000
986 DEEP VEIN THROMBOSIS 1 0.0000
987 PRODUCT QUALITY ISSUE 2 0.0000
988 MOBILITY DECREASED 1 0.0000
989 BRONCHITIS 1 0.0000
990 HOT FLUSH 1 0.0000
991 ACNE 1 0.0000
992 CARDIAC ARREST 1 0.0000
993 HYPERHIDROSIS 1 0.0000
994 BLOOD GLUCOSE INCREASED 1 0.0000